Albiglutide
CER-4-T2D
GSK · Phase n/r · Active, not recruiting · Enrollment 781430
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| SGLT-2i (Comparison 1) | n/r | n/r | n/r | n/r |
| DPP-4i (Comparison 1) | n/r | n/r | n/r | n/r |
| SGLT-2i (Comparison 2) | n/r | n/r | n/r | n/r |
| GLP-1 RA (Comparison 2) | n/r | n/r | n/r | n/r |
| GLP-1 RA (Comparison 3) | n/r | n/r | n/r | n/r |
| DPP-4i (Comparison 3) | n/r | n/r | n/r | n/r |
| SGLT-2i (Comparison 4) | n/r | n/r | n/r | n/r |
| SU (Comparison 4) | n/r | n/r | n/r | n/r |
| GLP-1 RA (Comparison 5) | n/r | n/r | n/r | n/r |
| SU (Comparison 5) | n/r | n/r | n/r | n/r |
| DPP-4i (Comparison 6) | n/r | n/r | n/r | n/r |
| SU (Comparison 6) | n/r | n/r | n/r | n/r |
| SGLT2i (Comparison 7) | n/r | n/r | n/r | n/r |
| GLP-1 RA (Comparison 7) | n/r | n/r | n/r | n/r |
| DPP-4i (Comparison 7) | n/r | n/r | n/r | n/r |
| SU (Comparison 7) | n/r | n/r | n/r | n/r |
| SGLT2i (Comparison 8) | n/r | n/r | n/r | n/r |
| GLP-1 RA (Comparison 8) | n/r | n/r | n/r | n/r |
| DPP-4i (Comparison 8) | n/r | n/r | n/r | n/r |
Not shown
- SGLT-2i (Comparison 1): endpoint not reported
- DPP-4i (Comparison 1): endpoint not reported
- SGLT-2i (Comparison 2): endpoint not reported
- GLP-1 RA (Comparison 2): endpoint not reported
- GLP-1 RA (Comparison 3): endpoint not reported
- DPP-4i (Comparison 3): endpoint not reported
- SGLT-2i (Comparison 4): endpoint not reported
- SU (Comparison 4): endpoint not reported
- GLP-1 RA (Comparison 5): endpoint not reported
- SU (Comparison 5): endpoint not reported
- DPP-4i (Comparison 6): endpoint not reported
- SU (Comparison 6): endpoint not reported
- SGLT2i (Comparison 7): endpoint not reported
- GLP-1 RA (Comparison 7): endpoint not reported
- DPP-4i (Comparison 7): endpoint not reported
- SU (Comparison 7): endpoint not reported
- SGLT2i (Comparison 8): endpoint not reported
- GLP-1 RA (Comparison 8): endpoint not reported
- DPP-4i (Comparison 8): endpoint not reported